Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II
B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrest
A novel DNA intercalator, butylamino-pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells
Differential gene expression triggered by highly cytotoxic α-Emitter-immunoconjugates in gastric cancer cells
Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics
Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer : A phase II trial
A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer : Eastern Cooperative Oncology Group Study 1503
Esophageal ulcer in a patient who received bevacizumab
Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment : Case report